Form D · Pharmaceuticals

Surterra Holdings, Inc./DE

Atlanta, GA · CIK 0001749034

Offering snapshot reported Apr 3, 2019 · SEC filing

Reported sold: $165M
Investors reported: 31
Minimum accepted: $0
First sale: Oct 16, 2018

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$54,632,654 → $165,427,654
Reported investors17 → 31

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 3, 2019	Amendment	$165,427,654	$110,795,000vs Oct 31, 2018	31	SEC filing
Oct 31, 2018	Initial	$54,632,654	No comparison	17	SEC filing
Aug 6, 2018	Initial	$65,000,000	No comparison	31	SEC filing

Offering details

Securities: Debt, Option to acquire
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-324745

Source: Form D, filed Apr 3, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Andrew Allen	Director
Jason Becker	Director
Robert Jacob Bergmann	Director, Executive
Jay Holmes	Director
Tom Venables	Director
Tim Vining	Director
James H. Whitcomb	Executive
William Wrigley Jr.	Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

55 Ivan Allen Jr. Boulevard Nw
Atlanta, GA, 30308